A review is given of the background to and results of the succesful pharmacological testing of [AuX2(damp)] (X CI, OAc; damp 2-Me,NCHzC6H4) against a range of microbes, fungi and turnouts, culminating in in vivo xenografts of ZR-1-75. These are the first fully evaluated gold(III) complexes. The activity and reactions of the diacetato-complex bear a resemblance to cisplatin, and some of the relevant chemistry is discussed. Preliminary screening data for C,P-chelated tertiary phosphine derivatives of gold(III) are presented.
INTRODUCTION
Given that the anti-tumor activity of platinum(II) has been investigated for over 30 years, it is surprising that gold(III) has received so little attention. The two are isoelectronic and isosteric: d' configurations and square-planar complexes; they undergo similar types of subsitution reactions.
There are two obvious problems. (a) The additional positive charge on the gold atom means that the ligand sets cannot be the same if the same overall charge is to be attained. Thus, for neutral complexes of the cisplatin type gold(III) would have to have three negatively charged ligands. (b) Compounds of gold show a distressing tendency to undergo reduction to the metal. Those who have attempted any synthetic chemistry in the field know how readily deposits of elemental gold appear.
It might be desirable to mimic some other features of active platinum compounds, e.g. the cisdisposition of two readily displaceable ligands and, perhaps, the presence of a primary or secondary amine ligand.
PREVIOUS WORK N,O-Systems
The above challenges are not difficult to overcome. We decided a few years ago to use chelating mono-negative ligands to force the cis geometry and to neutralise the third positive charge, and chose to begin with Schiff-bases and pyridine 2-carboxylates (l, 11). Complexes of the desired type can be obtained, albeit not without some difficulty (it is much easier to obtain the bis-chelated complexes than the monochelates, Equ 1). However, as soon as these materials encountered biological media, reduction to elemental gold occurred, presumably with oxidation of the cell-material and, hence, disastrous toxicity. (Table IV) . The highspot of the testing was the xenograft (human turnout lines grafted on to living nude mice). The pofiles (Fig. a) were not dissimilar to those of cisplatin, although the dose levels needed were rather higher. lz There was a possibility that the effectiveness of IV was being limited by its poor aqueous solubility, and it was suggested that the diacetato analogue, IX, might be better. The data here were very promising indeed in anti-bacterial and CHO tests (Tables I, Ill) and even better against the tumour lines (Tables I, V) . Of particular interest was the toxicity ,against CH1, one form of which is resistant to cisplatin.
-
The xenograft tests were also superb (Fig b) . Various biological mechanistic studies were carried out by Johnson Matthey s'4 which suggested, as might be expected, some differences from the mode of action of cisplatin. Meanwhile, we at UMIST were characterising IX and exploring its chemistry. One oddity was that the 3C NMR spectra showed a strange difference in intensity of the two sets of acetate peaks (Fig 2a) , which we eventually attributed to a hydrolysis reaction due to traces of water in the solvents; the pure D20 solution showed a very exaggerated intentsity difference (Fig 2b) . Confirmation was obtained by using bone-dry acetonitrile and deliberately adding water to it (Fig 2c,d) . It was then possible to see two stages of hydrolysis, one very fast, giving rapid exchange between co-ordinated and free acetate, and one much slower. The rapid one presumably involves the acetate trans to the labilising carbon ligand (Equ. 8, 9) . '3 These results were of great interest, since the mechanism of action of cisplatin is thought to depend on hydrolysis. 16 Clearl systems of this type bear further investigation, and we are arranging further screening tests on our gold(III) C,N-chelates. Modifications of the ligands are being made to attempt to obtain better initial solubilities.
P,C-Systems
It would clearly be prudent to examine other ligand systems, and we picked up an old but curious report by Martin Bennett, who showed that oxidation of gold(I) complexes of diphenylstyrylphosphine gave P,C chelate systems .(Scheme 2). 17 The chemistry of this system is very strange, invlvoing redistribution and redox reactions. 18 However, Johnson Matthey have performed preliminary antimicrobial screening. Activity was not very good (Tables 1,2) , slightly better for the dibromo derivative, probably because it is less insoluble. Both had to be dissolved in acetone before adding water; we are currently working on synthesising more soluble derivatives, and shall try again.
CONCLUSION
Gold(Ill) complexes have interesting biochemical activity provided that the ligands are chosen to stabilise the gold against reduction and to provide adequate solubility. It is certain that their mode of action
